Paper6185902
Retinal ischemia and risk of neovascularization following central retinal vein obstruction.
Magargal LE and 2 others. Ophthalmology, 1982. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Papers, record 6185902. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6185902
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Retinal ischemia and risk of neovascularization following central retinal vein obstruction.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ischemia | Major topic |
| Neovascularization, Pathologic | Major topic |
| Retinal Vein | Major topic |
| Retinal Vessels | Major topic |
| Fluorescein Angiography | |
| Glaucoma | |
| Humans | |
| Microcomputers | |
| Retinal Diseases | |
| Risk |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38259837 | The progress of assessment methods and treatments of neovascular glaucoma secondary to central retinal vein occlusion. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/38259837 | PubMed |
| 33494354 | Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion. | J Clin Med | 2021 | https://conductscience.org/library/papers/33494354 | PubMed |
| 32172031 | Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization. | Biomaterials | 2020 | https://conductscience.org/library/papers/32172031 | PubMed |
| 30972485 | A novel strategy for quantification of panoramic en face optical coherence tomography angiography scan field. | Graefes Arch Clin Exp Ophthalmol | 2019 | https://conductscience.org/library/papers/30972485 | PubMed |
| 29942024 | Relationship between Optical Intensity on Optical Coherence Tomography and Retinal Ischemia in Branch Retinal Vein Occlusion. | Sci Rep | 2018 | https://conductscience.org/library/papers/29942024 | PubMed |
| 28574924 | OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN RETINAL VEIN OCCLUSION: Correlations Between Macular Vascular Density, Visual Acuity, and Peripheral Nonperfusion Area on Fluorescein Angiography. | Retina | 2018 | https://conductscience.org/library/papers/28574924 | PubMed |
| 27490797 | Etiology and Features of Eyes with Rubeosis Iridis among Korean Patients: A Population-Based Single Center Study. | PLoS One | 2016 | https://conductscience.org/library/papers/27490797 | PubMed |
| 22960949 | A prospective, randomised, multicenter trial for surgical treatment of central retinal vein occlusion: results of the Radial Optic Neurotomy for Central Vein Occlusion (ROVO) study group. | Graefes Arch Clin Exp Ophthalmol | 2013 | https://conductscience.org/library/papers/22960949 | PubMed |
| 20379457 | Clinical progress in impending central retinal vein occlusion. | Korean J Ophthalmol | 2010 | https://conductscience.org/library/papers/20379457 | PubMed |
| 17406885 | Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series. | Graefes Arch Clin Exp Ophthalmol | 2007 | https://conductscience.org/library/papers/17406885 | PubMed |
| 12598443 | Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion. | Br J Ophthalmol | 2003 | https://conductscience.org/library/papers/12598443 | PubMed |
| 9349161 | Central retinal vein occlusion: what's the story? | Br J Ophthalmol | 1997 | https://conductscience.org/library/papers/9349161 | PubMed |
| 8910031 | Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischaemia and reperfusion in the rat. | Histochem J | 1996 | https://conductscience.org/library/papers/8910031 | PubMed |
| 7612574 | Electroretinogram as indicator of prognosis of central retinal vein occlusion. | Br J Ophthalmol | 1995 | https://conductscience.org/library/papers/7612574 | PubMed |
| 4016064 | Chronic ocular ischaemia. | Br J Ophthalmol | 1985 | https://conductscience.org/library/papers/4016064 | PubMed |
| 3966997 | A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. | Br J Ophthalmol | 1985 | https://conductscience.org/library/papers/3966997 | PubMed |
| 2361592 | Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. | Graefes Arch Clin Exp Ophthalmol | 1990 | https://conductscience.org/library/papers/2361592 | PubMed |
| 1714760 | Neovascular response in ischaemic central retinal vein occlusion after panretinal photocoagulation. | Br J Ophthalmol | 1991 | https://conductscience.org/library/papers/1714760 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6185902
GET https://conductscience.org/api/papers/v1/6185902/authors